Troy A. Ignelzi - 16 Dec 2022 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Chief Financial Officer
Signature: /s/ Troy Ignelzi
Issuer symbol: N/A
Transactions as of: 16 Dec 2022
Net transactions value: +$109,176
Form type: 4
Filing time: 19 Dec 2022, 15:24:16 UTC
Previous filing: 17 Nov 2022
Next filing: 19 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$99,995	+10,869	+109%	$9.20^*	20,839	16 Dec 2022	Direct
transaction	KRTX	Common Stock	Options Exercise	$3,413	+371	+1.8%	$9.20^*	21,210	16 Dec 2022	Direct
transaction	KRTX	Common Stock	Options Exercise	$5,768	+627	+3%	$9.20^*	21,837	16 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-10,869	-8.9%	$0.000000	110,743	16 Dec 2022	Common Stock	10,869	$9.20	Direct	F1
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-371	-4.2%	$0.000000	8,559	16 Dec 2022	Common Stock	371	$9.20	Direct	F2
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-627	-50%	$0.000000	626	16 Dec 2022	Common Stock	627	$9.20	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vested and became exercisable as to 1/4th of the shares underlying the option award on March 1, 2020, and continues to vest as to an additional 1/8th of the shares on each six month anniversary thereafter.
F2	This option vested as to 1/36th of the shares underlying the option award on each one month anniversary of the vesting commencement date of March 1, 2019.